업데이트됨
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
감염병학 2025의료 권고사항
임상 권고사항
의학회 및 보건 당국이 발표한 공식 권고사항, 합의문 및 업데이트를 확인하세요.
공식적이고 신뢰할 수 있는 출처의학회 및 보건 당국
최신 정보지속적인 과학적 모니터링
전문가를 위한 무료 이용의료 커뮤니티를 지원합니다
주요 간행물 및 업데이트
최근 발행물 보기
업데이트됨
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
심장학 2025
공식 발행
Evidence-informed diagnosis of cerebral palsy in community settings
Canadian Paediatric Society
소아과학 2026모든 권고사항 (결과 126개)
필터
Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovi...
Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17]”. NACI recommend...
Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz)
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 v...
Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]”. NACI recomme...
Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax CO...
Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6...
Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID...
Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]”. NACI i...
Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID...
Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]”. NACI up...